Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions

Autor: Ashwin Narayanan, David G. Standaert, Aseel Dib, Laura A. Volpicelli-Daley, Drake R. Thrasher, Jennifer Freire, Drèson L. Russell, Lindsay E. Stoyka, Andrew E. Arrant, Casey L. Mahoney
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
Conditioning
Classical

Parkinson’s disease dementia
Fear conditioning
Substantia nigra
Lewy neurites
Biology
Parkinson's disease dementia
Amygdala
Article
lcsh:RC321-571
Alpha-synuclein
03 medical and health sciences
0302 clinical medicine
Dopamine
Cortex (anatomy)
medicine
Animals
Dementia with Lewy Bodies
Prefrontal cortex
lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
Cerebral Cortex
Inclusion Bodies
Neurons
Social dominance
Behavior
Animal

Dementia with Lewy bodies
Pars compacta
Dopaminergic
Parkinson Disease
medicine.disease
Corpus Striatum
nervous system diseases
Excitatory neurons
Mice
Inbred C57BL

030104 developmental biology
medicine.anatomical_structure
nervous system
Neurology
Rotarod Performance Test
Cortex
Fibrils
Female
Lewy bodies
Neuroscience
030217 neurology & neurosurgery
medicine.drug
Zdroj: Neurobiology of disease
Neurobiology of Disease, Vol 134, Iss, Pp-(2020)
ISSN: 0969-9961
Popis: Parkinson's disease (PD) is defined by motor symptoms such as tremor at rest, bradykinesia, postural instability, and stiffness. In addition to the classical motor defects that define PD, up to 80% of patients experience cognitive changes and psychiatric disturbances, referred to as PD dementia (PDD). Pathologically, PD is characterized by loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and intracellular inclusions, called Lewy bodies and Lewy neurites, composed mostly of α-synuclein. Much of PD research has focused on the role of α-synuclein aggregates in degeneration of SNpc dopamine neurons because of the impact of loss of striatal dopamine on the classical motor phenotypes. However, abundant Lewy pathology is also found in other brain regions including the cortex and limbic brain regions such as the amygdala, which may contribute to non-motor phenotypes. Little is known about the consequences of α-synuclein inclusions in these brain regions, or in neuronal subtypes other than dopamine neurons. This project expands knowledge on how α-synuclein inclusions disrupt behavior, specifically non-motor symptoms of synucleinopathies. We show that bilateral injections of fibrils into the striatum results in robust bilateral α-synuclein inclusion formation in the cortex and amygdala. Inclusions in the amygdala and prefrontal cortex primarily localize to excitatory neurons, but unbiased stereology shows no significant loss of neurons in the amygdala or cortex. Fibril injected mice show defects in a social dominance behavioral task and fear conditioning, tasks that are associated with prefrontal cortex and amygdala function. Together, these observations suggest that seeded α-synuclein inclusion formation impairs behaviors associated with cortical and amygdala function, without causing cell loss, in brain areas that may play important roles in the complex cognitive features of PDD.
Databáze: OpenAIRE